Nome Químico: N-(1-Hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)stearamide
Sorrisos: OCC(NC(CCCCCCCCCCCCCCCCC)=O)(CO)CCC1=CC=C(CCCCCCCC)C=C1
Inchi: InChI=1S/C35H63NO3/c1-3-5-7-9-11-12-13-14-15-16-17-19-21-23-34(39)36-35(30-37,31-38)29-28-33-26-24-32(25-27-33)22-20-18-10-8-6-4-2/h24-27,37-38H,3-23,28-31H2,1-2H3,(H,36,39)
Fingolimod promotes angiogenesis and attenuates ischemic brain damage via modulating microglial polarization
KeShanga1JiaHeb1JingZoubChuanQinaLiLincLuo-QiZhouaLin-LinYangbLong-JunWudWeiWangaKe-BinZhanbDai-ShiTiana
Brain Research Volume 1726, 1 January 2020, 146509
Rapid Determination of Fingolimod Hydrochloride‑Related Substances and Degradation Products in API and Pharmaceutical Dosage Forms by Use of a Stability‑Indicating UPLC Method
N. Rajan · K. Anver Basha
Chromatographia (2014) 77:1545–1552
Development and validation of Immunomodulating drug Fingolimod by RPHPLC method with detailed force degradation study
Ravi V Ghediya1,2, Madhavi Patel1,2,3, Darshana Pandya1,2, Anamik K Shah1,2, Ranjan C Khunt
Chemistry & Biology Interface, 2016, 6, 4, 210-223